Jaguar Health Q2 EPS $(0.42), Sales $2.68M Down From $2.92M YoY
Portfolio Pulse from Benzinga Newsdesk
Jaguar Health (NASDAQ:JAGX) reported Q2 losses of $(0.42) per share, with sales of $2.68 million, marking an 8.39% decrease from the same period last year.
August 14, 2023 | 10:19 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Jaguar Health reported a Q2 loss and a decrease in sales compared to last year.
Jaguar Health's Q2 report shows a loss per share and a decrease in sales compared to the same period last year. This could negatively impact investor sentiment and potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100